EB003

DB18362ExperimentalGene Therapies

EB003 is a CRISPR-based sequence-specific antimicrobial (SSAM) targeted against shiga toxin-producing E. coli.

Code names
EB-003

What you can answer from here — as of March 06, 2025

1+ReferenceStructured and connected to the statements they support
Sign in

Which companies are running trials of EB003, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In